Oz's first confirmation hearing as nominee for CMS head is Friday. Back in 2016, Oz was named in a class action lawsuit ...

Deborah Grayson, who is also a nutritional therapist, says weight-loss injection companies will have to update their ...

Many are in the chase of quick fixes in weight loss, but more than often it's ineffective. Expert debunks 6 common weight ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

A study finds that significant weight loss increases the risk for individuals with cardiovascular disease. New research has ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

Season three of The White Lotus is causing waves, especially for its uneasy female friend group. The three women at the ...